Saltar al contenido principal
Pan y Hierro Nutrition and exercise with sources

Blog

Creatine: what the evidence says and where its limits are

Creatine: what the evidence says about strength, muscle mass and cognition, the studied dose, and why the effect is small.

Creatine monohydrate is the most effective nutritional ergogenic supplement available for increasing high-intensity exercise capacity and lean mass during training [1]. That headline sits alongside two other things: improvement figures of 10% to 20% in intense or repetitive effort [1], and a small effect on hypertrophy measured by imaging [2].

What the position stand supports

The field’s reference point is the position stand from the International Society of Sports Nutrition [1]. It is a narrative review from a scientific society, which translates the literature into an official position, not a meta-analysis with pooled figures of its own. Read the conclusions with that nuance in mind.

Its main points [1]:

  • Creatine supplementation increases muscle availability of creatine and phosphocreatine, which “may therefore improve acute exercise capacity and adaptations to training” in adolescents, young adults and older adults [1].
  • In the table of ergogenic benefits, after a loading phase, performance in high-intensity and/or repetitive exercise generally increases between 10% and 20%, depending on the magnitude of the rise in muscle phosphocreatine [1]. That is what the source says [1]. What it does not say is that creatine turns anyone into a different person.

The limit pages usually leave out: the size of the effect

Here is the honest part. A 2023 meta-analysis reviewed trials that measured hypertrophy with direct imaging (MRI, CT or ultrasound), in healthy adults aged 18 or over, with strength training and a minimum duration of 6 weeks [2].

The limit pages usually leave out: the size of the effect: Data · Value
Data Value
Studies included 10
Results analyzed 44
Muscle thickness (upper and lower body) 0.10-0.16 cm

The effect is small: in standardized mean difference, the pooled value across studies was 0.11 and its credibility interval includes zero, so the difference between treated and untreated groups could be nil [2]. In the upper body and in the lower body the effect was equally small. The centimeters in the table are the original measure; the 0.11 is the standardized version, not kilos or centimeters.

The authors themselves acknowledge a limit worth keeping in mind: only one study included women only [2].

That runs against the marketing promise: a 0.11 improvement is not a transformation. Watch one methodological detail: when “how much muscle you have” is measured with methods that depend on water, such as lean mass by DXA or bioelectrical impedance, creatine gains can look larger than they do with direct imaging. That is why that meta-analysis uses MRI, CT and ultrasound only [2].

Safety: what has been reviewed about the kidney

Here you have to separate the dates, because the kidney evidence has moved.

The 2019 review, the oldest of the four, screened 290 non-duplicate studies, included 15 in the qualitative analysis and 6 in the quantitative one [3]. Its summary is contradictory and has to be read carefully: it says supplementation “did not significantly alter” serum creatinine, and at the same time publishes a standardized mean difference that is small in size for serum creatinine and large for plasma urea [3]. In other words, the data do shift those markers; what the authors claim is that the change does not indicate kidney damage. Their literal conclusion is that creatine “does not induce kidney damage at the amounts and durations studied” [3].

A 2025 update, with 21 studies reviewed and 12 in the meta-analysis (177 supplemented participants and 263 in the control group), puts the same nuance: creatine is associated with a small, transient rise in serum creatinine with no significant change in glomerular filtration [4]. The effect was only significant in studies with one week of follow-up or less, and it stopped being significant from 12 weeks onward [4].

And two 2026 meta-analyses reach the same point. The first, limited to randomized trials (19 trials and one double-blind crossover study), found serum creatinine slightly higher, with no difference in urea or in estimated The second pooled 26 trials and 1,036 participants [6]. It found serum creatinine higher and creatinine-based estimated filtration lower. But when filtration was measured with Cr-EDTA, the difference was not statistically significant [6]. Creatinine itself influences the calculation of estimated filtration: these results do not prove kidney damage, but they do not establish safety for every population and every duration either.

Three limits that have to be said together:

  • “No kidney deterioration detected” is not “a healthy kidney in anyone at any dose”. It is what these studies found, in those populations and with those follow-ups.
  • The trials included different populations, including some with kidney disease and on hemodialysis [6]. Their results do not allow an individual conclusion for someone with pre-existing kidney disease. The position stand notes that people with pre-existing kidney disease have been advised to consult their doctor “out of an abundance of caution”, even though its conclusion is that there is no convincing evidence of harmful effects [1].
  • Filtration calculated from creatinine can change when this marker rises without an independent measurement confirming the same change [6].

Which kind of work it improves

One detail the literature explains better than it is usually told: creatine does not act as a more intense training stimulus, but rather increases muscle availability of creatine and phosphocreatine; the ISSN The practical consequence is that the type of work is not a detail:

  • In high-intensity and/or repetitive effort, the position stand records improvements of 10% to 20% after loading, depending on the rise in muscle phosphocreatine [1].
  • The same document shows, in the benefits table, a “possible improvement in aerobic capacity” [1]: that is a possibility flagged, not an established result, and this article puts no figure on it.

That is why claims about creatine are always paired with a type of exercise. Without that context, “creatine improves performance” is an incomplete sentence.

Clinical applications not covered here

The position stand also covers possible effects on post-exercise recovery, injury prevention, thermoregulation and rehabilitation, plus clinical applications in neurodegenerative disease, muscular dystrophy, diabetes, osteoarthritis, fibromyalgia and aging [1]. What can be said clearly is the safety part, covered above: well tolerated short and long term, up to 30 g/day for 5 years, in healthy people [1]. On the kidney, the conclusion holds across the four kidney reviews: no association with kidney damage at the amounts and durations studied, but they do shift serum creatinine [3] [4] [5] [6], and the 2026 review distinguishes between filtration estimated with creatinine and filtration measured with Cr-EDTA, which does not differ [6]. Trials longer than one year are still needed to settle long-term kidney safety [5].

What you take away

  1. Creatine increases muscle availability of creatine and phosphocreatine and improves performance in high-intensity and/or repetitive work, on the order of 10-20% after loading [1].
  2. For imaging-measured hypertrophy in healthy adults, the effect is small and the credibility interval includes zero [2].
  3. Creatine is well tolerated short and long term in healthy people, up to 30 g/day for 5 years, according to the ISSN [1].
  4. On the kidney, the 2025 and 2026 reviews find serum creatinine somewhat higher. The review of 26 trials found lower filtration estimated with creatinine, but no significant difference with Cr-EDTA; and trials longer than one year are still needed to assess long-term safety [4] [5] [6].
  5. With kidney disease, or during pregnancy, the decision is medical.

None of this is a recommendation to take creatine. It is what the evidence says, with its effect sizes, so that you can decide for yourself.

More at: the supplements page, with the figures and sources from the Nutrition section.

This article deliberately does not develop those clinical applications: they are medical indications, not public-health ones, and this site is not a professional-advice tool. They are also claims from a narrative review, not from a meta-analysis [1].

notes that this “may therefore improve acute exercise capacity and adaptations to training” [1]. Its position is defined for increasing high-intensity exercise capacity and lean mass during training [1].

glomerular filtration [5]. Its authors close by noting that randomized trials of more than one year are needed to settle long-term kidney safety [5].

  • Beyond performance, research has looked at effects on post-exercise recovery, injury prevention, thermoregulation and rehabilitation [1].
  • Clinical applications in neurodegenerative disease, muscular dystrophy, diabetes, osteoarthritis, fibromyalgia and aging have been studied [1].
  • Short- and long-term supplementation (up to 30 g/day for 5 years) is safe and well tolerated in healthy people and in patient populations ranging from infants to older adults [1].

Related articles

Sources for this article (6) 6 references
  1. Kreider RB, Kalman DS, Antonio J, et al. (2017) International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition 14:18. See source (opens in a new tab) DOI: 10.1186/s12970-017-0173-z Position Stand de la ISSN sobre creatina (revisión narrativa, no metaanálisis) Licence: Artículo de acceso abierto (BMC/Springer, CC BY 4.0). Se cita con enlace. Consulted:
  2. Burke R, Piñero A, Coleman M, et al. (2023) The Effects of Creatine Supplementation Combined with Resistance Training on Regional Measures of Muscle Hypertrophy: A Systematic Review with Meta-Analysis. Nutrients 15(9):2116. See source (opens in a new tab) DOI: 10.3390/nu15092116 Revisión sistemática y metaanálisis (10 estudios, ≥6 semanas,RM/TC/US): efecto muy pequeño de la creatina sobre hipertrofia medida por imagen Licence: Artículo de acceso abierto en PMC (MDPI, CC BY 4.0). Se cita con enlace. Consulted:
  3. de Souza E Silva A, Pertille A, Reis Barbosa CG, Aparecida de Oliveira Silva J, de Jesus DV, Ribeiro AGSV (2019) Effects of Creatine Supplementation on Renal Function: A Systematic Review and Meta-Analysis. Journal of Renal Nutrition 29(6):480-489. See source (opens in a new tab) DOI: 10.1053/j.jrn.2019.05.004 Revisión sistemática y metaanálisis sobre creatina y función renal en personas sanas Licence: Artículo de revista con derechos de autor. Se cita con enlace al editor; no se reproduce texto salvo cita breve verificable. Consulted:
  4. Kabiri Naeini E, Eskandari M, Mortazavi M, Gholaminejad A, Karevan N (2025) Effect of creatine supplementation on kidney function: a systematic review and meta-analysis. BMC Nephrology 26:622. See source (opens in a new tab) DOI: 10.1186/s12882-025-04558-6 Revisión sistemática y metaanálisis (21 estudios revisados, 12 en el metaanálisis): aumento pequeño y transitorio de creatinina sérica sin cambio en el filtrado glomerular Licence: Artículo de acceso abierto en PMC (BMC, CC BY 4.0). Se cita con enlace. Consulted:
  5. Tsiaras A, Loufopoulos G, Theodoridis X, Liakopoulos V, Poulia KA, Chourdakis M (2026) The Effect of Creatine Supplementation on Kidney Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Renal Nutrition. See source (opens in a new tab) DOI: 10.1053/j.jrn.2026.04.010 Revisión sistemática y metaanálisis de ensayos aleatorizados (19 ECA y un estudio de cruce): aumento de creatinina sérica sin cambio en urea ni en el filtrado glomerular estimado; faltan ECA de más de un año Licence: Artículo de revista con derechos de autor. Se cita con enlace al editor; no se reproduce texto salvo cita breve verificable. Consulted:
  6. de Souza Almeida A, da Silva L, Takahasi B, et al. (2026) Impact of creatine supplementation on kidney health: a systematic review and meta-analysis. International Urology and Nephrology. See source (opens in a new tab) DOI: 10.1007/s11255-026-05287-x Metaanálisis de 26 ensayos: creatinina más alta, filtrado estimado con creatinina más bajo y sin diferencia significativa con Cr-EDTA Licence: Artículo de revista citado con enlace al editor; no se reproduce el texto. Consulted:

How to cite

Pan y Hierro (2026). Creatine: what the evidence says and where its limits are. https://panyhierro.com/en/blog/creatine/. Updated October 12, 2026.